xanthenes has been researched along with Diabetic Retinopathy in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kogure, A; Takakura, Y; Toda, H; Umekawa, T; Yoshida, T; Yoshikawa, T; Yoshioka, K | 1 |
Harata, N; Kinukawa, J; Shimura, M; Tamai, M | 1 |
Gaylord, GM; Haselton, FR; Russ, PK | 1 |
L'Esperance, FA | 2 |
5 other study(ies) available for xanthenes and Diabetic Retinopathy
Article | Year |
---|---|
Fatty acid binding protein gene 2 polymorphism is not associated with diabetic retinopathy in Japanese type 2 diabetic patients.
Topics: Aged; Body Mass Index; Carrier Proteins; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Glycated Hemoglobin; Humans; Japan; Male; Middle Aged; Neoplasm Proteins; Polymerase Chain Reaction; Polymorphism, Genetic; Spectrometry, Fluorescence; Tumor Suppressor Proteins; Xanthenes | 2003 |
Gliclazide attenuates the intracellular Ca2+ changes induced in vitro by ischemia in the retinal slices of rats with streptozotocin-induced diabetes.
Topics: Aniline Compounds; Animals; Calcium; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Gliclazide; Glyburide; Hypoglycemic Agents; Ionomycin; Ionophores; Ischemia; Microscopy, Confocal; Rats; Rats, Sprague-Dawley; Retina; Streptozocin; Xanthenes | 2005 |
Retinal vascular permeability determined by dual-tracer fluorescence angiography.
Topics: Animals; Biomedical Engineering; Blood-Retinal Barrier; Capillary Permeability; Diabetic Retinopathy; Fluorescein; Fluorescein Angiography; Fluorescent Dyes; Humans; Image Processing, Computer-Assisted; In Vitro Techniques; Male; Mannitol; Rats; Retinal Vessels; Xanthenes | 2001 |
Trans-spectral organic dye laser photocoagulation.
Topics: Angiomatosis; Choroid Neoplasms; Coloring Agents; Diabetic Retinopathy; Eye Neoplasms; Fluorescein Angiography; Hemangioma; Humans; Laser Therapy; Light Coagulation; Macular Degeneration; Neovascularization, Pathologic; Retinal Diseases; Retinal Vein; Retinal Vessels; Rhodamines; Staining and Labeling; Xanthenes | 1985 |
Clinical applications of the organic dye laser.
Topics: Aged; Coloring Agents; Diabetic Retinopathy; Fluorescein Angiography; Humans; Laser Therapy; Light Coagulation; Macular Degeneration; Retinal Diseases; Retinal Vein; Rhodamines; Xanthenes | 1985 |